Growing evidence indicates that the expression or alteration of AQP3 in the intestine may be associated with a variety of intestinal disorders, including inflammatory bowel disease, diarrhea, intestinal barrier injury, irritable bowel syndrome, intestinal oxidative stress and autophagy (17). This evidence concerns the gene AQP3 and irritable bowel syndrome.